Analysed ZENAS BIOPHARMA INC (ZBIO:NASDAQ) News Sources
Zenas BioPharma Announces Upcoming Presentation of Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD) at EULAR 2026 Congress
19-05-2026
yahoo.com
Zenas BioPharma Announces Submission of Biologics License Application (BLA) to U.S. FDA for Obexelimab in IgG4-RD
28-05-2026
yahoo.com
A Look At Zenas BioPharma (ZBIO) Valuation After Strong 1-Year Return And Recent Share Price Weakness
01-06-2026
yahoo.com
Zenas BioPharma Announces Data from the Registrational Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD), Simultaneously Presented at the EULAR 2026 Congress and Published in the New England Journal of Medicine
02-06-2026
yahoo.com
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Wednesday Amid Fresh Economic Signals
03-06-2026
yahoo.com
Zenas BioPharma to Present at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
11-06-2026
yahoo.com
Zenas BioPharma's CEO Purchased 60,000 Company Shares. Here's a Deeper Look at the Transaction.
21-06-2026
fool.com
Zenas BioPharma Bear Case Overlooks Obexelimab's Commercial Potential, Wedbush Says
17-07-2026
yahoo.com
What is the current price of ZENAS BIOPHARMA INC (ZBIO:NASDAQ)?
The current price of ZENAS BIOPHARMA INC (ZBIO:NASDAQ) is $29.53.
ZENAS BIOPHARMA INC (ZBIO:NASDAQ) absolute price change since previous trading day?
The absolute price change of ZENAS BIOPHARMA INC (ZBIO:NASDAQ) since the previous trading day is $1.29.
ZENAS BIOPHARMA INC (ZBIO:NASDAQ) percentage price change since previous trading day?
The percentage price change of ZENAS BIOPHARMA INC (ZBIO:NASDAQ) since the previous trading day is 4.568%.
What is the most recent average sentiment score for ZENAS BIOPHARMA INC (ZBIO:NASDAQ)?
The most recent average sentiment score for ZENAS BIOPHARMA INC (ZBIO:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for ZENAS BIOPHARMA INC (ZBIO:NASDAQ)?
The most recent sentiment for ZENAS BIOPHARMA INC (ZBIO:NASDAQ) is .
SEC-8K** Filing Available For ZENAS BIOPHARMA INC (ZBIO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.